InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Aiello Joshua. Director active across 1 company, notably Orchestra BioMed Holdings, Inc.. Aggregated, 2 disclosures have been recorded. History available since 20 July 2023. The latest transaction was disclosed on 26 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations